Economic outcomes of implantable cardioverter-defibrillators

Circulation

Volumn 101, Issue 9, 2000, Pages 1067-1074

  Stanton, Marshall S ^a   Bell, Gregory K ^a,b  

^a MEDTRONIC INC   (United States)

^b CHARLES RIVER ASSOCIATES   (United States)

Author keywords

Cardioversion; Cost benefit analysis; Defibrillation

Indexed keywords

CARDIOVERSION; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DEFIBRILLATOR; FOLLOW UP; HEART FIBRILLATION; IMPLANTATION; MONITORING; OUTCOMES RESEARCH; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW;

EID: 0034005813     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.101.9.1067     Document Type: Review

References (21)

1. Zipes DP, Wyse DG, Friedman PL, Epstein AE, Hallstrom AP, Greene HL, Schron EB, Domanski M. The Antiarrhythmics Versus Implantable Defibrillators (AVID) Investigators. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near fatal ventricular arrhythmias. N Engl J Med. 1997;337:1576-1583.
2. Connolly SJ. Heart failure and arrhythmia: results from the Canadian Implantable Defibrillator Study (CIDS) [press release]. Bethesda, Md: American College of Cardiology (ACC 98 NewsOnline); April 1, 1998. Available at: www.acc.org/members/session X/conf98/news
3. Kuck K. Heart failure and arrhythmia: Cardiac Arrest Study Hamburg (CASH) [press release5D. Bethesda, Md: American College of Cardiology (ACC 98 NewsOnline); April 1, 1998. Available at: www.acc.org/ members/session X/conf98/news
4. Moss AJ, Hall WJ, Cannom DS, Daubert JP, Higgins SL, Klein H, Levine JH, Saksena S, Waldo AL, Wilber D, Brown MW, Heo M. Improved survival with an implanted defibrillator in patients with coronary artery disease at high risk for ventricular arrhythmia. N Engl J Med. 1996;335: 1933-1940.
5. Valenti R, Schlapfner J, Fromer M, Fischer A, Kappenberger L. Impact of the implantable cardioverter-defibrillator on rehospitalizations. Eur Heart J. 1996;17:1565-1571.
6. Kupersmith J, Hogan A, Guerrero P, Gardiner J, Mellits D, Baumgardner R, Rovner D, Holmes-Rovner M, McLane A, Levine J, Saksena S, Griffith L. Evaluating and improving the cost effectiveness of the implantable cardioverter-defibrillator. Am Heart J. 1995;130(pt 1):507-515.
7. US Price Database. Lexington, Mass: Standard & Poor's DRI/ McGraw-Hill; 1997.
8. Drummond M, O'Brien B, Stoddart GL, Torrance GW. Methods for the Economic Evaluation of Health Care Programmes. New York, NY: Oxford University Press; 1997.
9. Gold M, Siegel JE, Russell LB, Weinstein MC. Cost-Effectiveness in Health and Medicine. New York, NY: Oxford University Press; 1996.
10. Kupersmith J, Holmes-Rovner M, Hogan A, Rovner D, Gardiner J. Cost effectiveness analysis in heart disease, part III: ischemia, congestive heart failure, and arrhythmias. Prog Cardiovasc Dis. 1995;37:307-346.
11. Larsen GC, McAnulty JH, Hallstrom A, Marchant C, Shein M, Akiyama T, Brodsky M, Baessler C, Pinski, SL, Jennings CA, Morris M. Hospitalization charges in the antiarrhythmics versus implantable defibrillators (AVID) trial: the AVID economic analysis study. Circulation. 1997; 96(suppl I):I-77. Abstract.
12. Wever EF, Hauer RN, Schrijvers G, van Capelle FL, Tijssen JG, Crijns HJ, Algra A, Ramanna H, Bakker PF, de Medina EO. Cost effectiveness of implantable defibrillator as first-choice therapy versus electrophysiologically guided, tiered strategy in postinfarct sudden death survivors. Circulation. 1996;93:489-496.
13. Micro Jewel II Arrhythmia Management Device Product Information Manual. Model 7223 Cx. Minneapolis, Minn: Medtronic Inc; 1996:1:25. 4:24.
14. Micro Jewel II Arrhythmia Management Device Product Information Manual. Model 7223 Cx. Minneapolis, Minn: Medtronic Inc; 1996:1:25. 4:24.
15. A Guide to the Operation and Programming of the 7271 GEM DR Dual-Chamber Implantable Cardioverter-Defibrillator. Minneapolis. Minn: Medtronic Inc; September 1997:1-5. System reference guide, 9960E software.
16. Mushlin A, Hall WJ, Zwanziger J, Gajary E, Andrews M, Marron R, Zou K, Moss A. The cost effectiveness of automatic implantable cardiac defibrillators: results from MADIT. Circulation. 1998;97:2129-2135.
17. Larsen GC, Manolis AS, Sonnenberg FA, Beshansky JR, Estes NA, Pauker SG. Cost effectiveness of the implantable cardioverter-defibrillator: effect of improved battery life and comparison with amiodarone therapy. J Am Coll Cardiol. 1992;19:323-334.
18. Owens DK, Sanders GD, Harris RA, McDonald KM, Heidenreich PA, Dembitzer AD, Hlatky MA. Cost effectiveness of implantable cardioverter defibrillators relative to amiodarone for prevention of sudden cardiac death. Ann Intern Med. 1997;126:1-12.
19. Hauer RN, Derksen R, Wever EF. Can implantable cardioverter-defibrillator therapy reduce healthcare costs? Am J Cardiol. 1996;78: 134-139.
20. Kuppermann M, Luce BR, McGovern B, Podrid PJ, Bigger JT Jr, Ruskin JN. An analysis of the cost effectiveness of the implantable defibrillators. Circulation. 1990;81:91-100.
21. Cardinal DS, Connelly DT, Steinhaus DM, Lemery R, Waters M, Foley L. Cost savings with nonthoracotomy implantable cardioverter-defibrillators. Am J Cardiol. 1996;78:1255-1259.